38.96
-0.75(-1.89%)
Currency In USD
| Previous Close | 39.71 |
| Open | 39.46 |
| Day High | 39.48 |
| Day Low | 38.84 |
| 52-Week High | 60.87 |
| 52-Week Low | 27.34 |
| Volume | 825,802 |
| Average Volume | 1.8M |
| Market Cap | 3.58B |
| PE | -33.02 |
| EPS | -1.18 |
| Moving Average 50 Days | 33.03 |
| Moving Average 200 Days | 36.95 |
| Change | -0.75 |
If you invested $1000 in Legend Biotech Corporation (LEGN) since IPO date, it would be worth $1,052.97 as of July 13, 2025 at a share price of $38.96. Whereas If you bought $1000 worth of Legend Biotech Corporation (LEGN) shares 3 years ago, it would be worth $707.72 as of July 13, 2025 at a share price of $38.96.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire Inc.
May 19, 2025 12:00 PM GMT
SOMERSET, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on Sunday, June 1, 2025, at 6:00 p.m. CT (7:00 p.m. ET) durin
Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results
GlobeNewswire Inc.
Apr 29, 2025 12:00 PM GMT
SOMERSET, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, May 13, 2025, to review first-quarte
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results
GlobeNewswire Inc.
Feb 25, 2025 1:00 PM GMT
SOMERSET, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, March 11, 2025, to review fourth-quar